Loading...

Sonic Healthcare Limited

SKHHYPNK
HealthcareMedical - Diagnostics & Research
$16.04
$-0.02(-0.12%)

Sonic Healthcare Limited (SKHHY) Stock Overview

Explore Sonic Healthcare Limited’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
12.17%
12.17%
Profit Growth
$1.07
25.39%
EPS Growth
$1.07
26.71%
Operating Margin
6.27%
0.47%
ROE
6.54%
25.39%
Dividend Yield
0.00%
2.59%

Analyst Recommendations

Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0

Price Targets

Low$28.10
Average$30.15
High$32.20

Company Profile

Sonic Healthcare Limited offers medical diagnostic services in Australia. The company provides laboratory medicine/pathology; diagnostic imaging/radiology, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry; and primary care medical services comprising general practice services, occupational health services, remote health services, community and home nursing services, primary care research programs, health assessment technologies, clinical trials, and chronic disease management programs to clinicians, hospitals, community health services, and their patients. It also offers administrative services and facilities to medical practitioners. The company operates in Australia, New Zealand, the United Kingdom, the United States, Germany, Switzerland, Belgium, and Ireland. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.

CEO

Dr. Colin Stephen Goldschmidt F.A.C.I.D., F.A.I.C.D., F.R.C.P.A., M.B.B.Ch.

Employees

42,000

Headquarters

Grosvenor Place, Sydney, NSW

Founded

2010

Frequently Asked Questions

Meyka LogoMeyka

Meyka is the best Alternative Data platform powered by AI providing research insights for investors

Connect With Us

Legal Disclaimer

The information provided by Meyka AI PTY LTD is for informational and research purposes only and does not constitute financial, investment, or trading advice. Meyka is a research platform, not a financial advisory service. Investing in financial markets involves risks, and past performance does not guarantee future results. Users should conduct their own due diligence, consult with professional financial advisors, and assess their risk tolerance before making investment decisions. Meyka and its operators are not liable for any financial losses incurred from the use of information on this platform. The data provided is derived from publicly available sources and is believed to be reliable but may not always be accurate or up to date. Users should independently verify information and not rely solely on Meyka for financial decisions. By using Meyka, you acknowledge that it does not provide financial advice or recommendations and agree to seek guidance from a qualified financial professional before making any investment decisions.

© 2025 Meyka AI PTY LTD. All rights reserved.